NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10

被引:70
|
作者
Sun, Yingjia [1 ]
Ai, Xinghao [1 ]
Shen, Shengping [1 ]
Lu, Shun [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Lung Tumor Clin Med Ctr, Shanghai 200030, Peoples R China
关键词
NSCLC; miR-124; MYO10; NF-kappa B; metastasis; TUMOR-GROWTH; MICRORNA; EXPRESSION; INVASION;
D O I
10.18632/oncotarget.3135
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, dysregulation of microRNAs plays a critical role in cancer metastasis. Here, an in vivo selection approach was used to generate highly aggressive NSCLC sub-cell lines followed by comparing the microRNAs expression using microarrays. miR-124 was notably deregulated in both highly invasive sub-cell lines and nodepositive NSCLC specimens. Over-expression of miR-124 robustly attenuated migration and metastatic ability of the aggressive cells. MYO10 was subsequently identified as a novel functional downstream target of miR-124, and was up-regulated in nodepositive NSCLC tissues. Knockdown of MYO10 inhibited cell migration, whereas forced MYO10 expression markedly rescued miR-124-mediated suppression of cell metastasis. Additionally, we found an activated NF-kappa B-centered inflammatory loop in the highly aggressive cells leading to down-regulation of miR-124. These results suggest that NF-kappa B-regulated miR-124 targets MYO10, inhibits cell invasion and metastasis, and is down-regulated in node-positive NSCLC.
引用
收藏
页码:8244 / 8254
页数:11
相关论文
共 50 条
  • [1] miR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer
    Chen, Cai-Ping
    Sun, Zong-Lin
    Lu, Xiang
    Wu, Wan-Xin
    Am, Wen-Li
    Lu, Jian-Ju
    Han, Chao
    Huang, Jian-Qi
    Fang, Ying
    ONCOLOGY REPORTS, 2016, 35 (02) : 709 - 716
  • [2] miR-147a suppresses the metastasis of non-small-cell lung cancer by targeting CCL5
    Lu, Yan
    Luan, Xiao Rong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019,
  • [3] Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer
    Kim, Young Hun
    Lee, Won Kee
    Lee, Eung Bae
    Son, Ji Woong
    Kim, Dong Sun
    Park, Jae Yong
    CLINICAL LUNG CANCER, 2017, 18 (01) : E13 - E20
  • [4] Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer
    Chen, Wei-Ting
    Chen, Ying-Kai
    Lin, Song-Shei
    Hsu, Fei-Ting
    ANTICANCER RESEARCH, 2018, 38 (04) : 2161 - 2167
  • [5] Abietic acid suppresses non-small-cell lung cancer cell growth via blocking IKKβ/NF-κB signaling
    Liu, Xueping
    Chen, Wei
    Liu, Quanxing
    Dai, Jigang
    ONCOTARGETS AND THERAPY, 2019, 12 : 4825 - 4837
  • [6] Inhibition of LHX2 by miR-124 suppresses cellular migration and invasion in non-small cell lung cancer
    Yang, Qinghui
    Wan, Liang
    Xiao, Can
    Hu, Haibo
    Wang, Longqiang
    Zhao, Jun
    Lei, Zhe
    Zhang, Hong-Tao
    ONCOLOGY LETTERS, 2017, 14 (03) : 3429 - 3436
  • [7] LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer
    Wu, Jiasheng
    Weng, Yueyue
    He, Fei
    Liang, Dong
    Cai, Lin
    ANTI-CANCER DRUGS, 2018, 29 (07) : 628 - 636
  • [8] miR-449a Suppresses Tumor Growth, Migration, and Invasion in Non-Small Cell Lung Cancer by Targeting a HMGB1-Mediated NF-κB Signaling Pathway
    Wu, Dandan
    Liu, Jun
    Chen, Jianliang
    He, Haiyan
    Ma, Hang
    Lv, Xuedong
    ONCOLOGY RESEARCH, 2019, 27 (02) : 227 - 235
  • [9] MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9
    Liang, Zhihua
    Xu, Jianhui
    Ma, Zhancheng
    Li, Guihua
    Zhu, Wanhong
    BIOENGINEERED, 2020, 11 (01) : 70 - 80
  • [10] Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis
    Jiang, Jie
    Geng, Guojun
    Yu, Xiuyi
    Liu, Hongming
    Gao, Jing
    An, Hanxiang
    Cai, Chengfu
    Li, Ning
    Shen, Dongyan
    Wu, Xiaoqiang
    Zheng, Lisheng
    Mi, Yanjun
    Yang, Shuyu
    ONCOTARGET, 2016, 7 (52) : 87271 - 87283